Your trusted source for investing success
By Bala Yogesh
Which NASDAQ tech stocks gained the most last week? Mattersight Corporation, RealNetworks, Meet Group, Iteris Inc and Computer Task Group were the top gainers.
By Bala Yogesh
Which NASDAQ tech stocks gained the most last week? Zix, Sify, Simulation Plus, eGain and Cyren were the top gainers.
By Jocelyn Aspa
Cyren, Sify Technologies, Internap, JMU and Marchex were last week’s top gainers.
By Jocelyn Aspa
RealNetworks, Intevac, Attunity, Cyren, and Computer Task Group were last week’s top gainers.
By Jocelyn Aspa
eGain, Synchronoss Technologies, Park City Group, Meet Group and Avid Technology were last week’s top gainers.
ChroMedX Corp. (CSE: CHX) (OTCQB: CHXIF) (FSE: EIY2) (the “Company”), developer of the HemoPalm Handheld Blood Analyzer System, is pleased to announce the formation of an evaluation team for the analysis of the Company’s patented Automated Ultrafiltration Technology (AUF).
Todos Medical (OTCQB:TOMDF) a clinical-stage in-vitro diagnostics company focused on the development of blood tests for the early detection of cancer, announced today that the U.S. Patent and Trademark Office has granted to Todos Medical two patents for broader claims for its inventions.
As quoted in the press release:
The first patent
Avalon GloboCare (OTCQB: AVCO), a leading global developer of cell-based technologies, announced that the Company has formed a strategic partnership with Da An Gene Co., Ltd, a major biomedical company publicly listed on the Shenzhen Stock Exchange (002030.SZ), to further optimize Avalon’s exosome-based technology, clinical development, as well as product commercialization.
As
By Jocelyn Aspa
Internap, Computer Task Group, Magic Software, Bsquare and Evolving Systems were last week’s top gainers.
ChroMedX Corp. (CSE: CHX) (OTCQB: CHXIF) (FSE: EIY2) (the “Company”), developer of the HemoPalm Handheld Blood Analyzer System, is pleased to announce the appointments of Dr. Richard Janeczko as Chief Commercial Officer (CCO) and Jessica Kuhn as Chief Operations Officer (COO). Dr. Janeczko and Ms. Kuhn’s positions are effective immediately.
By Jocelyn Aspa
NetSol Technologies, American Software, Evolving Systems, Perion Network, and eGain were last week’s top gainers.
By Micha Boon
ChroMedX Corp. (CSE:CHX) (OTCQB: CHXIF) (FSE: EIY2) (the “Company”), developer of the HemoPalm Handheld Blood Analyzer System, is pleased to announce the appointments of MedTech visionary Lahav Gil as Chief Executive Officer and W. Clark Kent as President of the Company. Both have also been appointed to the Company’s board
By Micha Boon
ChroMedX Corp. (CSE:CHX) (OTC:CHXIF) (FSE: EIY2), (the “Company”), developer of the HemoPalm Handheld Blood Analyzer System, is pleased to report on the signing of a definitive agreement with diagnostic marketing experts DxEconomix Inc. (DxEx) to conduct a high value transaction for the Company.
In August 2017 ChroMedX retained the consulting company
By Micha Boon
ChroMedX Corp. (CSE:CHX) (OTC: CHXIF) (FSE: EIY2) (the “Company”), developer of the HemoPalm Handheld Blood Analyzer System, is pleased to announce that since November 2017 investors have exercised warrants to acquire 1,031,000 new common shares of the Company as of December 12, 2017.
The total consideration received was CAD$226,200. The Warrant
By Micha Boon
ChroMedX Corp. (CSE:CHX) (OTCQB: CHXIF) (FSE: EIY2) (the “Company”), developer of the HemoPalm Handheld Blood Analyzer System, is pleased to announce the appointment of Dr. Richard Janeczko to the Company’s Board of Directors. This appointment is consistent with the Company’s strategy to strengthen its business development and commercialization team through
By Micha Boon
ChroMedX Corp. (the “Company”) (CSE:CHX) (OTCQB: CHXIF) (FSE: EIY2), developer of the HemoPalm Handheld Blood Analyzer System, is pleased to report that the Company is now in the process of mass manufacturing the HemoPalm’s biosensor component at the ChroMedX lab in Ontario, Canada. The Company also announces the appointment of
By Micha Boon
ChroMedX Corp. (CSE:CHX) (OTCQB: CHXIF) (FSE: EIY2) (the “Company”), developer of the HemoPalm Handheld Blood Analyzer System, is pleased to announce that it has entered into a binding Letter of Intent (“LOI”) with Glendale, California headquartered diagnostic marketing specialist Dx Econmix Inc. (DxEx) to conduct a high value transaction for
By Micha Boon
ChroMedX Corp. (CSE:CHX) (OTCQB: CHXIF) (FSE: EIY2) (the “Company”), developer of the HemoPalm Handheld Blood Analyzer System, is pleased to announce that it has entered into a binding Letter of Intent (“LOI”) with Glendale, California headquartered diagnostic marketing specialist Dx Econmix Inc. (DxEx) to conduct a high value transaction for
By Micha Boon
ChroMedX Corp. (CSE:CHX) (OTCQB: CHXIF) (FSE: EIY2) (the “Company”) is pleased to announce that it has closed a non-brokered private placement (the “Offering”) of 7,570,500 units (“Units”) at a price of $0.20 per Unit for aggregate gross proceeds of $1,514,100. Each Unit is comprised of one common share of the
By Jocelyn Aspa
USA Technologies, Avid Technology, Evolving Systems, Internap, and JMU were last week’s top gainers.
